Janssen vaccine



J&J adds to COVID-19 vaccine armory with 66% efficacy in global trial

  • J&J will seek emergency use authorization in U.S. next week
  • The pharmaceutical giant has said it plans to deliver 1 billion doses in 2021
By Reuters ·